Overview

Pharmacokinetic Comparison of Multiple Formulations of Topiramate and Phentermine in Obese Adults

Status:
Completed
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to describe the single- and multiple-dose pharmacokinetic profiles of two novel formulations of topiramate and commercially available immediate release topiramate, all dosed with immediate release phentermine.
Phase:
Phase 1
Details
Lead Sponsor:
VIVUS, Inc.
Treatments:
Phentermine
Topiramate